Adult urological soft tissue sarcomas: A multicenter study of the anatolian society of medical oncology (ASMO)

Basit Öğe Kaydı
dc.authorscopusid55313987900
dc.authorscopusid6603573888
dc.authorscopusid56304997100
dc.authorscopusid24339272800
dc.authorscopusid55653083100
dc.authorscopusid56478832600
dc.authorscopusid55582896100
dc.contributor.authorUnal O.U.
dc.contributor.authorOztop I.
dc.contributor.authorMenekse S.
dc.contributor.authorUrakci Z.
dc.contributor.authorBozkurt O.
dc.contributor.authorOzcelik M.
dc.contributor.authorGunaydin Y.
dc.date.accessioned2024-06-12T10:27:54Z
dc.date.available2024-06-12T10:27:54Z
dc.date.issued2015
dc.description.abstractObjective: To analyze clinicopathological characteristics, prognostic factors and survival rates of the patients with urological soft tissue sarcomas treated and followed up in Turkey. Materials and Methods: For overall survival analyses the Kaplan-Meier method was used. From medical records, nine prognostic factors on overall survival were analysed. Results: For the 53 patients (34 males, 19 females) whose charts were reviewed, the median age was 53 (range 22 to 83) years. Most frequently renal location (n=30; 56.6%) was evident and leiomyosarcoma (n=20, 37.7%) was the most frequently encountered histological type. Median survival time of all patients was 40.3 (95% CI, 14.2-66.3) months. In univariate analysis, male gender, advanced age (=50 years), metastatic stage, unresectability, grade 3, renal location were determined as worse prognostic factors. In multivariate analysis, metastatic stage, unresectability and grade 3 were determined as indicators of worse prognosis. Conclusions: Urological soft tissue sarcomas are rarely seen tumours in adults. The most important factors in survival are surgical resection, stage of the tumour at onset, grade and location of the tumour, gender and age of the patients.en_US
dc.identifier.doi10.7314/APJCP.2015.16.11.4777
dc.identifier.endpage4780en_US
dc.identifier.issn1513-7368
dc.identifier.issue11en_US
dc.identifier.pmid26107239en_US
dc.identifier.scopus2-s2.0-84936972915en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage4777en_US
dc.identifier.urihttps://doi.org/10.7314/APJCP.2015.16.11.4777
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16957
dc.identifier.volume16en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAsian Pacific Organization for Cancer Preventionen_US
dc.relation.ispartofAsian Pacific Journal of Cancer Preventionen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPrognostic Factors; Survival; Turkey; Urologic Sarcomaen_US
dc.subjectAdult; Aged; Cancer Grading; Cancer Staging; Clinical Trial; Female; Follow Up; Human; Male; Metastasis; Middle Aged; Mortality; Multicenter Study; Pathology; Prognosis; Sarcoma; Survival Rate; Urologic Neoplasms; Very Elderly; Young Adult; Adult; Aged; Aged, 80 And Over; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Sarcoma; Survival Rate; Urologic Neoplasms; Young Adulten_US
dc.titleAdult urological soft tissue sarcomas: A multicenter study of the anatolian society of medical oncology (ASMO)en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu